CC
GBT

Carlson Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Carlson Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400,000
Closed -$27.2M – 160
2022
Q3 		$27.2M Buy
+400,000
New +$22.1M 2.05% 14

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Carlson Capital's GBT Position: Q4 2022 in Review

Carlson Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 400,000 shares — an estimated $27.2M sold.

Carlson Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $27.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Carlson Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Carlson Capital sold 400,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $27.2M.
  • Carlson Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Carlson Capital's Global Blood Therapeutics, Inc. position peaked at $27.2M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Carlson Capital's 13F filing for Q4 2022, filed 14 Feb 2023.